Biotricity Alpha and Beta Analysis
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Biotricity. It also helps investors analyze the systematic and unsystematic risks associated with investing in Biotricity over a specified time horizon. Remember, high Biotricity's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Biotricity's market risk premium analysis include:
Beta 0.15 | Alpha (1.05) | Risk 0.0 | Sharpe Ratio 0.0 | Expected Return 0.0 |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Biotricity |
Biotricity Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Biotricity market risk premium is the additional return an investor will receive from holding Biotricity long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Biotricity. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Biotricity's performance over market.| α | -1.05 | β | 0.15 |
Biotricity Fundamentals Vs Peers
Comparing Biotricity's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Biotricity's direct or indirect competition across all of the common fundamentals between Biotricity and the related equities. This way, we can detect undervalued stocks with similar characteristics as Biotricity or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Biotricity's fundamental indicators could also be used in its relative valuation, which is a method of valuing Biotricity by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Biotricity to competition |
| Fundamentals | Biotricity | Peer Average |
| Return On Equity | -41.01 | -0.31 |
| Return On Asset | -0.89 | -0.14 |
| Profit Margin | (1.17) % | (1.27) % |
| Operating Margin | (0.96) % | (5.51) % |
| Current Valuation | 38.87 M | 16.62 B |
| Shares Outstanding | 21.48 M | 571.82 M |
| Shares Owned By Insiders | 48.61 % | 10.09 % |
Biotricity Opportunities
Biotricity Return and Market Media
The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | 12 Health Care Stocks Moving In Thursdays Intraday Session - 180 Life Sciences , Biotricity - Benzinga | 05/16/2024 |
2 | Biotricity Preferred Shareholders Show Increased Commitment and Support of the Company by Converting Almost All Preferred A Shares into Restricted Common Stock | 06/04/2024 |
3 | Biotricity Launches Direct-to-Consumer Heart Health Screening Service, HeartSecure, Making Heart Health Services Accessible in Response to the 1 Global Killer, ... | 06/12/2024 |
4 | Biotricity Reports Strong Results with Revenue Growth, Continued Margin Improvement, and Reduced Operating Expenses for Fiscal Year 2024, Accelerating the Compa... | 06/27/2024 |
5 | Biotricity Launches HeartSecure Immediate, At-Home Cardiac Screening Now Available | 06/28/2024 |
6 | Biotricity Announces Accelerated Path to EBITDA Positive | 07/11/2024 |
7 | Enlivex Therapeutics and Biotricity Interviews to Air on the RedChip Small Stocks, Big Money Show on Bloomberg TV | 07/19/2024 |
8 | LOBO EV and Nexalin Interviews to Air on the RedChip Small Stocks, Big Money Show on Bloomberg TV | 07/26/2024 |
About Biotricity Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Biotricity or other delisted stocks. Alpha measures the amount that position in Biotricity has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Biotricity Upcoming Company Events
As portrayed in its financial statements, the presentation of Biotricity's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Biotricity's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Biotricity's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Biotricity. Please utilize our Beneish M Score to check the likelihood of Biotricity's management manipulating its earnings.
| 13th of February 2024 Upcoming Quarterly Report | View | |
| 4th of July 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 4th of July 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of March 2023 Last Financial Announcement | View |
Build Portfolio with Biotricity
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Consideration for investing in Biotricity Stock
If you are still planning to invest in Biotricity check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Biotricity's history and understand the potential risks before investing.
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |